Francisco Lozano
@frguez.bsky.social
Médico especialista en Estomatología. Máster en tabaquismo. Chair of the board of CPE (Cancer Patients Europe)
Former ENSP and CNPT president
Tenerife-Bruselas
Former ENSP and CNPT president
Tenerife-Bruselas
Reposted by Francisco Lozano
🎙️Don’t miss it!
Webinar “How to Unlock Patient Insights Through Patient Advocacy Group Collaboration”
🗓️ 22 October
🕔 5 PM CEST / 11 AM EST
🔗 Register now: lnkd.in/dUC2M3xT
👉 Learn more: lnkd.in/ddMFDibP
Webinar “How to Unlock Patient Insights Through Patient Advocacy Group Collaboration”
🗓️ 22 October
🕔 5 PM CEST / 11 AM EST
🔗 Register now: lnkd.in/dUC2M3xT
👉 Learn more: lnkd.in/ddMFDibP
October 22, 2025 at 8:13 AM
🎙️Don’t miss it!
Webinar “How to Unlock Patient Insights Through Patient Advocacy Group Collaboration”
🗓️ 22 October
🕔 5 PM CEST / 11 AM EST
🔗 Register now: lnkd.in/dUC2M3xT
👉 Learn more: lnkd.in/ddMFDibP
Webinar “How to Unlock Patient Insights Through Patient Advocacy Group Collaboration”
🗓️ 22 October
🕔 5 PM CEST / 11 AM EST
🔗 Register now: lnkd.in/dUC2M3xT
👉 Learn more: lnkd.in/ddMFDibP
Reposted by Francisco Lozano
🚨 New Brachytherapy Patient Survey!
CPE would like to hear from cancer patients about their awareness & access to brachytherapy, a targeted radiation treatment that can improve outcomes & reduce side effects.
Your voice matters!
👉 Take the survey: lnkd.in/di7nW5cr
CPE would like to hear from cancer patients about their awareness & access to brachytherapy, a targeted radiation treatment that can improve outcomes & reduce side effects.
Your voice matters!
👉 Take the survey: lnkd.in/di7nW5cr
October 23, 2025 at 10:39 AM
🚨 New Brachytherapy Patient Survey!
CPE would like to hear from cancer patients about their awareness & access to brachytherapy, a targeted radiation treatment that can improve outcomes & reduce side effects.
Your voice matters!
👉 Take the survey: lnkd.in/di7nW5cr
CPE would like to hear from cancer patients about their awareness & access to brachytherapy, a targeted radiation treatment that can improve outcomes & reduce side effects.
Your voice matters!
👉 Take the survey: lnkd.in/di7nW5cr
Reposted by Francisco Lozano
💊 A strong EU biosimilar policy is key to progress in cancer care.
Don't miss our event “Building Equity, Access & Sustainability in Cancer Care with an EU Biosimilar Policy & Strategy”
📍4 Nov 2025, @europarl.europa.eu
⏰09:00-10:30
Registrations: lnkd.in/di6H7kHd
Don't miss our event “Building Equity, Access & Sustainability in Cancer Care with an EU Biosimilar Policy & Strategy”
📍4 Nov 2025, @europarl.europa.eu
⏰09:00-10:30
Registrations: lnkd.in/di6H7kHd
October 24, 2025 at 2:39 PM
💊 A strong EU biosimilar policy is key to progress in cancer care.
Don't miss our event “Building Equity, Access & Sustainability in Cancer Care with an EU Biosimilar Policy & Strategy”
📍4 Nov 2025, @europarl.europa.eu
⏰09:00-10:30
Registrations: lnkd.in/di6H7kHd
Don't miss our event “Building Equity, Access & Sustainability in Cancer Care with an EU Biosimilar Policy & Strategy”
📍4 Nov 2025, @europarl.europa.eu
⏰09:00-10:30
Registrations: lnkd.in/di6H7kHd
Reposted by Francisco Lozano
💊 20 years of biosimilars in Europe. Let’s keep building equitable access for all patients.
Don't miss our event at the @europarl.europa.eu:
📍SPINELLI 1G369
🗓️4 November 2025 (9:00-10:30)
🔗Registrations: lnkd.in/di6H7kHd
➡️Learn more: lnkd.in/d4GGyxY8
Don't miss our event at the @europarl.europa.eu:
📍SPINELLI 1G369
🗓️4 November 2025 (9:00-10:30)
🔗Registrations: lnkd.in/di6H7kHd
➡️Learn more: lnkd.in/d4GGyxY8
October 27, 2025 at 1:09 PM
💊 20 years of biosimilars in Europe. Let’s keep building equitable access for all patients.
Don't miss our event at the @europarl.europa.eu:
📍SPINELLI 1G369
🗓️4 November 2025 (9:00-10:30)
🔗Registrations: lnkd.in/di6H7kHd
➡️Learn more: lnkd.in/d4GGyxY8
Don't miss our event at the @europarl.europa.eu:
📍SPINELLI 1G369
🗓️4 November 2025 (9:00-10:30)
🔗Registrations: lnkd.in/di6H7kHd
➡️Learn more: lnkd.in/d4GGyxY8
Reposted by Francisco Lozano
📢 CPE joined the 6th HTA Stakeholder Network Meeting in Brussels to champion meaningful patient input in JCA.
Together with the European Patients Forum, CPE is co-leading a new project to strengthen patient and caregiver voices in EU HTA.
🔗 Learn more: lnkd.in/diVgKTfa
Together with the European Patients Forum, CPE is co-leading a new project to strengthen patient and caregiver voices in EU HTA.
🔗 Learn more: lnkd.in/diVgKTfa
October 27, 2025 at 2:53 PM
📢 CPE joined the 6th HTA Stakeholder Network Meeting in Brussels to champion meaningful patient input in JCA.
Together with the European Patients Forum, CPE is co-leading a new project to strengthen patient and caregiver voices in EU HTA.
🔗 Learn more: lnkd.in/diVgKTfa
Together with the European Patients Forum, CPE is co-leading a new project to strengthen patient and caregiver voices in EU HTA.
🔗 Learn more: lnkd.in/diVgKTfa
Reposted by Francisco Lozano
⌛One week to go!
📢Registrations close on thursday! lnkd.in/di6H7kHd
Join us at the @europarl.europa.eu on 4 November for our event "Building Equity, Access & Sustainability in Cancer Care with an EU Biosimilar Policy & Strategy".
💡Why attend? lnkd.in/dgsRSmp3
📢Registrations close on thursday! lnkd.in/di6H7kHd
Join us at the @europarl.europa.eu on 4 November for our event "Building Equity, Access & Sustainability in Cancer Care with an EU Biosimilar Policy & Strategy".
💡Why attend? lnkd.in/dgsRSmp3
October 28, 2025 at 9:40 AM
⌛One week to go!
📢Registrations close on thursday! lnkd.in/di6H7kHd
Join us at the @europarl.europa.eu on 4 November for our event "Building Equity, Access & Sustainability in Cancer Care with an EU Biosimilar Policy & Strategy".
💡Why attend? lnkd.in/dgsRSmp3
📢Registrations close on thursday! lnkd.in/di6H7kHd
Join us at the @europarl.europa.eu on 4 November for our event "Building Equity, Access & Sustainability in Cancer Care with an EU Biosimilar Policy & Strategy".
💡Why attend? lnkd.in/dgsRSmp3
Reposted by Francisco Lozano
📢 CPE at the World Orphan Drug Congress Europe 2025: Advancing patient involvement in JCAs for ATMPs.
CPE highlighted the need for early, structured patient input to ensure faster, fairer access across Europe.
🔗 Read more: lnkd.in/d9-ZbxM3
CPE highlighted the need for early, structured patient input to ensure faster, fairer access across Europe.
🔗 Read more: lnkd.in/d9-ZbxM3
October 30, 2025 at 11:33 AM
📢 CPE at the World Orphan Drug Congress Europe 2025: Advancing patient involvement in JCAs for ATMPs.
CPE highlighted the need for early, structured patient input to ensure faster, fairer access across Europe.
🔗 Read more: lnkd.in/d9-ZbxM3
CPE highlighted the need for early, structured patient input to ensure faster, fairer access across Europe.
🔗 Read more: lnkd.in/d9-ZbxM3
Reposted by Francisco Lozano
📢 CPE at the EACR–OECI Virtual Event: Patient Involvement in Cancer Research
Patient involvement is not optional, but essential to delivering better, more equitable cancer research and care.
🔗 Learn more: lnkd.in/g7XqjknM
Patient involvement is not optional, but essential to delivering better, more equitable cancer research and care.
🔗 Learn more: lnkd.in/g7XqjknM
October 31, 2025 at 9:56 AM
📢 CPE at the EACR–OECI Virtual Event: Patient Involvement in Cancer Research
Patient involvement is not optional, but essential to delivering better, more equitable cancer research and care.
🔗 Learn more: lnkd.in/g7XqjknM
Patient involvement is not optional, but essential to delivering better, more equitable cancer research and care.
🔗 Learn more: lnkd.in/g7XqjknM
Reposted by Francisco Lozano
🎗️October is Breast Cancer Awareness Month 2025
🩷 Together, let’s close the knowledge and access gaps in breast cancer care.
🔗 Learn more about our work on Genomic Testing: lnkd.in/dT39mg_U
🔗 Learn more on our ESR1 & Liquid Biopsy project: lnkd.in/d2ygNAXC
🩷 Together, let’s close the knowledge and access gaps in breast cancer care.
🔗 Learn more about our work on Genomic Testing: lnkd.in/dT39mg_U
🔗 Learn more on our ESR1 & Liquid Biopsy project: lnkd.in/d2ygNAXC
October 31, 2025 at 11:40 AM
🎗️October is Breast Cancer Awareness Month 2025
🩷 Together, let’s close the knowledge and access gaps in breast cancer care.
🔗 Learn more about our work on Genomic Testing: lnkd.in/dT39mg_U
🔗 Learn more on our ESR1 & Liquid Biopsy project: lnkd.in/d2ygNAXC
🩷 Together, let’s close the knowledge and access gaps in breast cancer care.
🔗 Learn more about our work on Genomic Testing: lnkd.in/dT39mg_U
🔗 Learn more on our ESR1 & Liquid Biopsy project: lnkd.in/d2ygNAXC
Reposted by Francisco Lozano
📢 Continuing the Momentum for Pancreatic Cancer Across Europe
👉 Read the full update on progress and next steps: lnkd.in/gE2CePqy
👉 Read the full update on progress and next steps: lnkd.in/gE2CePqy
Since the publication of the Pancreatic Cancer Across Europe Position Paper in May 2024, our partner organisations have continued working to turn its recommendations into tangible progress.
Read the full update on what has been achieved so far: shorturl.at/pod8H
Read the full update on what has been achieved so far: shorturl.at/pod8H
October 31, 2025 at 1:59 PM
📢 Continuing the Momentum for Pancreatic Cancer Across Europe
👉 Read the full update on progress and next steps: lnkd.in/gE2CePqy
👉 Read the full update on progress and next steps: lnkd.in/gE2CePqy
Reposted by Francisco Lozano
📢 CPE at the PREVENT 4th Plenary Meeting in Gorizia!
CPE remains committed to patient-centred engagement, supporting PREVENT in promoting healthy lifestyles for children across Europe.
🔗 Learn more: lnkd.in/dFprNDcd
CPE remains committed to patient-centred engagement, supporting PREVENT in promoting healthy lifestyles for children across Europe.
🔗 Learn more: lnkd.in/dFprNDcd
November 3, 2025 at 2:08 PM
📢 CPE at the PREVENT 4th Plenary Meeting in Gorizia!
CPE remains committed to patient-centred engagement, supporting PREVENT in promoting healthy lifestyles for children across Europe.
🔗 Learn more: lnkd.in/dFprNDcd
CPE remains committed to patient-centred engagement, supporting PREVENT in promoting healthy lifestyles for children across Europe.
🔗 Learn more: lnkd.in/dFprNDcd
Reposted by Francisco Lozano
🚀 Happening Now at the European Parliament!
Building Equity, Access, and Sustainability in Cancer Care with an EU Biosimilar Policy and Strategy.
🔗 Learn more here: lnkd.in/dgsRSmp3
Building Equity, Access, and Sustainability in Cancer Care with an EU Biosimilar Policy and Strategy.
🔗 Learn more here: lnkd.in/dgsRSmp3
November 4, 2025 at 9:13 AM
🚀 Happening Now at the European Parliament!
Building Equity, Access, and Sustainability in Cancer Care with an EU Biosimilar Policy and Strategy.
🔗 Learn more here: lnkd.in/dgsRSmp3
Building Equity, Access, and Sustainability in Cancer Care with an EU Biosimilar Policy and Strategy.
🔗 Learn more here: lnkd.in/dgsRSmp3
Reposted by Francisco Lozano
🏥Los medicamentos biosimilares han ayudado a millones de pacientes a luchar contra el cáncer.
Pero aún debemos garantizar que todos los europeos puedan acceder a tratamientos eficaces y asequibles.
El acceso es la clave.
🗣️ @nicogcasares.bsky.social
🇪🇺 @cancerpatientseu.bsky.social
Pero aún debemos garantizar que todos los europeos puedan acceder a tratamientos eficaces y asequibles.
El acceso es la clave.
🗣️ @nicogcasares.bsky.social
🇪🇺 @cancerpatientseu.bsky.social
November 4, 2025 at 8:27 AM
🏥Los medicamentos biosimilares han ayudado a millones de pacientes a luchar contra el cáncer.
Pero aún debemos garantizar que todos los europeos puedan acceder a tratamientos eficaces y asequibles.
El acceso es la clave.
🗣️ @nicogcasares.bsky.social
🇪🇺 @cancerpatientseu.bsky.social
Pero aún debemos garantizar que todos los europeos puedan acceder a tratamientos eficaces y asequibles.
El acceso es la clave.
🗣️ @nicogcasares.bsky.social
🇪🇺 @cancerpatientseu.bsky.social
Reposted by Francisco Lozano
📢 Advancing Equity and Patient Voice in Cancer Care: Spain’s Response to the EU HTA Regulation
🔗 Read more about the event in our article: lnkd.in/d-XZJreU
🔗 Read more about the event in our article: lnkd.in/d-XZJreU
November 4, 2025 at 4:47 PM
📢 Advancing Equity and Patient Voice in Cancer Care: Spain’s Response to the EU HTA Regulation
🔗 Read more about the event in our article: lnkd.in/d-XZJreU
🔗 Read more about the event in our article: lnkd.in/d-XZJreU
Reposted by Francisco Lozano
🎙️ Don’t miss it!
Registrations are still open for Digestive Cancers Europe's webinar “Patents: Empowering Advocates Through Knowledge”.
🗓️Thursday, 6 November 2025
🕔 4:00–5:30 PM CET
➡️Learn more: lnkd.in/d7M4z2Ur
Registrations are still open for Digestive Cancers Europe's webinar “Patents: Empowering Advocates Through Knowledge”.
🗓️Thursday, 6 November 2025
🕔 4:00–5:30 PM CET
➡️Learn more: lnkd.in/d7M4z2Ur
November 5, 2025 at 3:23 PM
🎙️ Don’t miss it!
Registrations are still open for Digestive Cancers Europe's webinar “Patents: Empowering Advocates Through Knowledge”.
🗓️Thursday, 6 November 2025
🕔 4:00–5:30 PM CET
➡️Learn more: lnkd.in/d7M4z2Ur
Registrations are still open for Digestive Cancers Europe's webinar “Patents: Empowering Advocates Through Knowledge”.
🗓️Thursday, 6 November 2025
🕔 4:00–5:30 PM CET
➡️Learn more: lnkd.in/d7M4z2Ur
Reposted by Francisco Lozano
📢 Bridging Policy and Patient Access: Making the EU HTA Regulation Work for Patients.
CPE & @pce-europe.bsky.social explored explore the impact of the EU HTA Regulation on patient access.
🔗Learn more: lnkd.in/dFTK83eh
CPE & @pce-europe.bsky.social explored explore the impact of the EU HTA Regulation on patient access.
🔗Learn more: lnkd.in/dFTK83eh
November 6, 2025 at 9:44 AM
📢 Bridging Policy and Patient Access: Making the EU HTA Regulation Work for Patients.
CPE & @pce-europe.bsky.social explored explore the impact of the EU HTA Regulation on patient access.
🔗Learn more: lnkd.in/dFTK83eh
CPE & @pce-europe.bsky.social explored explore the impact of the EU HTA Regulation on patient access.
🔗Learn more: lnkd.in/dFTK83eh
Reposted by Francisco Lozano
📢 Building Equity, Access, and Sustainability in Cancer Care with an EU Biosimilar Policy and Strategy: CPE’s High-Level Policy Event at the European Parliament.
🔗 Learn more: lnkd.in/dpKUummP
🔗 Learn more: lnkd.in/dpKUummP
November 7, 2025 at 10:03 AM
📢 Building Equity, Access, and Sustainability in Cancer Care with an EU Biosimilar Policy and Strategy: CPE’s High-Level Policy Event at the European Parliament.
🔗 Learn more: lnkd.in/dpKUummP
🔗 Learn more: lnkd.in/dpKUummP
Reposted by Francisco Lozano
#GlobalBiosimilarsWeek 2025 comes to an end!
💡 Biosimilars are reshaping healthcare, improving access, fostering innovation & generating savings for better care.
🔗Read more: lnkd.in/dNegRwWS
➡️Learn more: lnkd.in/dpKUummP
💡 Biosimilars are reshaping healthcare, improving access, fostering innovation & generating savings for better care.
🔗Read more: lnkd.in/dNegRwWS
➡️Learn more: lnkd.in/dpKUummP
#GlobalBiosimilarsWeek 2025 ends today!
This week, we talked about how biosimilars have helped reshape healthcare . Yet, unequal access remains a major challenge in 🇪🇺 & beyond.
To unlock their full potential, we must work together with policymakers and healthcare professionals #GBSW25
This week, we talked about how biosimilars have helped reshape healthcare . Yet, unequal access remains a major challenge in 🇪🇺 & beyond.
To unlock their full potential, we must work together with policymakers and healthcare professionals #GBSW25
November 7, 2025 at 1:53 PM
#GlobalBiosimilarsWeek 2025 comes to an end!
💡 Biosimilars are reshaping healthcare, improving access, fostering innovation & generating savings for better care.
🔗Read more: lnkd.in/dNegRwWS
➡️Learn more: lnkd.in/dpKUummP
💡 Biosimilars are reshaping healthcare, improving access, fostering innovation & generating savings for better care.
🔗Read more: lnkd.in/dNegRwWS
➡️Learn more: lnkd.in/dpKUummP
Reposted by Francisco Lozano
📢 Thank You for Sharing Your Voice!
CPE thanks more than 1,400 cancer patients who answered our survey on combination therapies.
🔗 Read more: lnkd.in/d2ws7uzu
CPE thanks more than 1,400 cancer patients who answered our survey on combination therapies.
🔗 Read more: lnkd.in/d2ws7uzu
November 7, 2025 at 4:02 PM
📢 Thank You for Sharing Your Voice!
CPE thanks more than 1,400 cancer patients who answered our survey on combination therapies.
🔗 Read more: lnkd.in/d2ws7uzu
CPE thanks more than 1,400 cancer patients who answered our survey on combination therapies.
🔗 Read more: lnkd.in/d2ws7uzu
Reposted by Francisco Lozano
📢 CPE at the Alira Health Webinar: Unlocking Patient Insights Through Meaningful Collaboration
🔗 Learn more: lnkd.in/dSUYFhNq
🔗 Learn more: lnkd.in/dSUYFhNq
November 11, 2025 at 5:34 PM
📢 CPE at the Alira Health Webinar: Unlocking Patient Insights Through Meaningful Collaboration
🔗 Learn more: lnkd.in/dSUYFhNq
🔗 Learn more: lnkd.in/dSUYFhNq
Reposted by Francisco Lozano
📢 CPE joined the 1st EP PerMed Expert Symposium in Bilbao!
CPE highlighted how patient advocacy and HTA can turn innovation into real impact.
🔗Read more: lnkd.in/daWrFUNh
CPE highlighted how patient advocacy and HTA can turn innovation into real impact.
🔗Read more: lnkd.in/daWrFUNh
November 12, 2025 at 10:19 AM
📢 CPE joined the 1st EP PerMed Expert Symposium in Bilbao!
CPE highlighted how patient advocacy and HTA can turn innovation into real impact.
🔗Read more: lnkd.in/daWrFUNh
CPE highlighted how patient advocacy and HTA can turn innovation into real impact.
🔗Read more: lnkd.in/daWrFUNh
Reposted by Francisco Lozano
📌CPE participated in the European Access Academy (EAA) Fall Convention 2025 in Paris!
CPE is committed to embedding patient voices in Europe’s HTA to drive real impact.
🔗 Read more: lnkd.in/d-byCcSz
👉 Learn more: lnkd.in/diVgKTfa
CPE is committed to embedding patient voices in Europe’s HTA to drive real impact.
🔗 Read more: lnkd.in/d-byCcSz
👉 Learn more: lnkd.in/diVgKTfa
November 12, 2025 at 2:47 PM
📌CPE participated in the European Access Academy (EAA) Fall Convention 2025 in Paris!
CPE is committed to embedding patient voices in Europe’s HTA to drive real impact.
🔗 Read more: lnkd.in/d-byCcSz
👉 Learn more: lnkd.in/diVgKTfa
CPE is committed to embedding patient voices in Europe’s HTA to drive real impact.
🔗 Read more: lnkd.in/d-byCcSz
👉 Learn more: lnkd.in/diVgKTfa
Reposted by Francisco Lozano
📌 #SaveTheDate: 7th European Cancer Forum 2025
CPE is proud to support the 7th European Cancer Forum!
📍 Brussels | 🗓️ 4 Dec | 🕛 09:30–14:00 CET
🔗 Registrations: lnkd.in/d8UatNRr
➡️ Read more: lnkd.in/d_x-ASw
CPE is proud to support the 7th European Cancer Forum!
📍 Brussels | 🗓️ 4 Dec | 🕛 09:30–14:00 CET
🔗 Registrations: lnkd.in/d8UatNRr
➡️ Read more: lnkd.in/d_x-ASw
November 12, 2025 at 5:01 PM
📌 #SaveTheDate: 7th European Cancer Forum 2025
CPE is proud to support the 7th European Cancer Forum!
📍 Brussels | 🗓️ 4 Dec | 🕛 09:30–14:00 CET
🔗 Registrations: lnkd.in/d8UatNRr
➡️ Read more: lnkd.in/d_x-ASw
CPE is proud to support the 7th European Cancer Forum!
📍 Brussels | 🗓️ 4 Dec | 🕛 09:30–14:00 CET
🔗 Registrations: lnkd.in/d8UatNRr
➡️ Read more: lnkd.in/d_x-ASw